Renal excretion of emtricitabine I: Effects of organic anion, organic cation, and nucleoside transport inhibitors on emtricitabine excretion

Journal of Pharmaceutical Sciences

Volumn 97, Issue 12, 2008, Pages 5401-5410

  Nakatani Freshwater, Tomoko ^a   Taft, David R ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

Emtricitabine; Isolated perfused kidney; Renal excretion

Indexed keywords

CIMETIDINE; EMTRICITABINE; PROBENECID; TETRYLAMMONIUM; TRIMETHOPRIM; URIDINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATED KIDNEY; MALE; NONHUMAN; RAT; TRANSPORT KINETICS; URINARY EXCRETION;

EID: 57349120095     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21370     Document Type: Article

References (29)

1. Gilead Sciences, Inc. 2005. U.S. Package Insert, Emtriva® (emtricitabine) Capsules. www.gilead.com/pdf/emtriva_pi.pdf.
2. FDA. 2003. Center for Drug Evaluation and Research, Clinical Pharmacology and Biopharmaceutics Review, Application Number 21-500, Emtriva, http://www.fda.gov/cder/foi/nda/2003/21-500_Emtriva_BioPharmr_P1.pdf.
3. Sweeney KR, Hsyu P-H, Statkevich P, Taft DR. 1995. Renal disposition and drug interaction screening of (-)-2/-deoxy-3/-thiacytidine (3tc) in the isolated perfused rat kidney. Pharm Res 12:1958-1963.
4. Nakatani-Freshwater T, Babayeva M, Dontabhaktuni A, Taft DR. 2006. Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and lamivudine in the isolated perfused rat kidney. J Pharmacol Exp Ther 319:941-947.
5. Takubo T, Kato T, Kinami J, Hanada K, Ogata H. 2000. Effect of trimethoprim on the renal clearance of lamivudine in rats. J Pharm Pharmacol 52:315-320.
6. Moore KHP, Yuen GJ, Raasch RH, Eron JJ, Martin D, Mydlow PK, Hussey EK. 1996. Pharmacokinetics of lamivudine administered alone and with trimethoprim. Clin Pharm Ther 59:550-558.
7. Sabo JP, Lamson MJ, Leitz G, Yong CL, Mac Gregor TR. 2002. Pharmacokinetics of nevirapine and lamivudine in patients with HIV-1 infection. AAPS PharmSci 2:1-8.
8. Bowman RH. 1975. The perfused rat kidney. Methods Enzymol 39:3-11.
9. Bowman RH. 1978. Methodology for study of isolated perfused rat kidney in vitro. In: Martinez-Maldonado M, editor. Methods in pharmacology, Vol. 4B, Renal pharmacology. New York: Plenum Press. pp 50-57.
10. Nishitsutsuji-Uwo JM, Ross BD, Krebs HA. 1967. Metabolic activities of the isolated perfused rat kidney. Biochem J 103:852-862.
11. Bekersky I. 1983. Use of the isolated perfused kidney as a tool in drug disposition studies. Drug Metab Rev 14:931-960.
12. Poola NR, Bhuyian D, Ortiz S, Savant IA, Sidhom M, Taft DR, Kirschenbaum H, Kalis M. 2002. A novel HPLC assay for pentamidine: Comparative effects of creatinine and inulin on GFR estimation and pentamidine renal excretion in the isolated perfused rat kidney. J Pharm Sci 5:135-145.
13. Tucker GT. 1981. Measurement of the renal clearance of drugs. Br J Pharmacol 12:761-770.
14. Taft DR. 2004. The isolated perfused rat kidney: A useful tool for drug discovery and development. Curr Drug Discov Technol 1:97-111.
15. Sawyer JP, Shiveley L, Franklin R. 2005. Pharmacokinetics of AVX754 in combination with trimethoprim/sulphamethoxazole. Proceedings and Abstracts of the 45th ICAAC. Washington, DC: American Society for Microbiology. [Abstract A-1201].
16. Takubo T, Kato T, Kinami J, Hanada K, Ogata H. 2000. Effect of lamivudine on uptake of organic cations by rat renal brush-border and basolateral membrane vesicles. J Pharm Pharmacol 52:569-575.
17. Leung S, Bendayan R. 2001. Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line. Can J Physiol Pharmacol 79:59-66.
18. Karbach U, Kricke J, Meyer-Wentrup F, Gorboulev V, Volk C, Loffing-Cueni D, Kaissling B, Bachmann S, Koepsell H. 2000. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol 279:F679-F687.
19. Kaewmokul S, Chatsudthipong V, Evans KK, Dantzler WH, Wright SH. 2003. Functional mapping of rbOCT1 and rbOCT2 activity in the S2 segment of rabbit proximal tubule. Am J Physiol Renal Physiol 285:F1149-F1159.
20. Wright SH, Evans KK, Zhang X, Cherrington NJ, Sitar DS, Dantzler WH. 2004. Functional map of TEA transport activity in isolated rabbit renal proximal tubules. Am J Physiol Renal Physiol 287:F442-F451.
21. Kuttesch JF, Robins MJ, Nelson JA. 1982. Renal transport of 2′-deoxytubercidin in mice. Biochem Pharmacol 31:3387-3394.
22. Nelson JA, Kuttesch JR, Herbert BH. 1983. Renal secretion of purine nucleosides and their analogs in mice. Biochem Pharmacol 32:2323-2327.
23. Aiba T, Sakurai Y, Tsukada S, Koizumi T. 1995. Effects of probenecid and cimetidine on the renal excretion of 3′-azido-3′-deoxythymidine in rats. J Pharmacol Exp Ther 272:94-99.
24. Chen R, Nelson JA. 2000. Role of organic cation transporters in the renal secretion of nucleosides. Biochem Pharmacol 60:215-219.
25. Chen R, Jonker JW, Nelson JA. 2002. Renal organic cation and nucleoside transport. Biochem Pharmacol 64:185-190.
26. Takubo T, Kato T, Kinami J, Hanada K, Ogata H. 2000. Effect of lamivudine on uptake of organic cations by rat renal brush-border and basolateral membrane vesicles. J Pharm Pharmacol 52:569-575.
27. Mangravite LM, Badagnani I, Giacomini KM. 2003. Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. Eur J Pharmacol 479:269-281.
28. Gray JH, Owen RP, Giacomini KM. 2004. The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447:728-734.
29. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. 2004. The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447:735-743.